Pharma Pulse 3/13/25: Trends Shaping Direct to Patient in Pharma, Empowering Pharmacies to Add New Sustainable Care Services & more

Trends Shaping Direct to Patient in Pharma

Direct-to-patient models are being utilized more and more in recent years. While this provides pharma companies with new opportunities to reach patient populations, it also creates new complications that they need to find solutions for. Scott Snyder, chief digital officer at EVERSANA, spoke with Pharmaceutical Executive about these types of models and the solutions that companies are employing.

Empowering Pharmacies to Add New Sustainable Care Services

A new free resource provides clear insights on contracted rates, enabling pharmacies to fill the community care gap.

University of South Florida Gets $40 Million to Start Cyber and AI College

Philanthropists Arnie and Lauren Bellini donate what is the largest gift in the school’s history, hoping to turn the Tampa Bay area into ‘Cyber Bay.’

ViiV Healthcare Announces New Implementation Study Data Showing Zero Cases of HIV with Apretude

ViiV Healthcare announced new data from two implementation studies showing zero cases of HIV acquisition for Apretude, the only long-acting injectable approved for HIV prevention. Real-world data were also presented for Cabenuva, the only approved, complete long-acting injectable treatment regimen, showing its effectiveness in the three years since it has been available.

Nicholas Saraceno on LinkedIn

Next week, Donald Tracy, MA and I will be heading down I-95 to Philly for #AccessUSA! On behalf of Pharmaceutical Commerce Magazine, we'll be covering sessions and conducting interviews for both #PAP2025 and #HubsEast2025 to explore the latest dynamics impacting patient outcomes, improving the patient experience, and driving access.

If you'll be there, let's connect!

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs